We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Must Update the FDA on Postmarket Trial Progress
Sponsors Must Update the FDA on Postmarket Trial Progress
April 18, 2012
While most drugmakers are good about keeping postmarket clinical trials on schedule, they don’t always file their required annual status reports on time.